Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of Nosocomial Acquired COVID-19 Patients

NCT04748588 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT04748588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04748588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of Nosocomial Acquired COVID-19 Patients
Lead sponsor
University of Calgary
Phase
Phase 4
Overall status
Terminated
Start date
February 12, 2021
Completion date
January 31, 2022
Enrollment
46 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, nosocomial infection, sars-cov2 infection